Skip to main content
Taylor & Francis Group Logo
Advanced Search

Click here to search books using title name,author name and keywords.

  • Login
  • Hi, User  
    • Your Account
    • Logout
Advanced Search

Click here to search books using title name,author name and keywords.

Breadcrumbs Section. Click here to navigate to respective pages.

Chapter

Disease State Management in Older Persons with Hyperlipidemia

Chapter

Disease State Management in Older Persons with Hyperlipidemia

DOI link for Disease State Management in Older Persons with Hyperlipidemia

Disease State Management in Older Persons with Hyperlipidemia book

Disease State Management in Older Persons with Hyperlipidemia

DOI link for Disease State Management in Older Persons with Hyperlipidemia

Disease State Management in Older Persons with Hyperlipidemia book

ByLouis Roller, Jenny Gowan
BookPatient Compliance with Medications

Click here to navigate to parent product.

Edition 1st Edition
First Published 2007
Imprint CRC Press
Pages 22
eBook ISBN 9780429131110

ABSTRACT

This chapter attempts to outline the complexity in treating older persons with risk factors for cardiovascular and/or cerebrovascular disease, with particular emphasis on hyperlipidemia. Adverse effects of many drugs may increase an individual’s risk of falls. Combinations of any of these agents will further increase risk plus environmental factors. A number of studies report that in older adults, high cholesterol levels pose a significant risk for death from coronary artery disease, while some others have suggested that lowering cholesterol levels in older persons may increase the risk for stroke or heart attack. The Cox-2 inhibitors may elicit a similar range of adverse reactions to the traditional nonsteroidal antiinflammatory drugs and also increase the risk of cardiovascular disease. The antibiotic combination, trimethoprim/sulfamethoxazole, has been associated with an increased risk of serious adverse reactions in older people, including bone marrow depression and serious skin reactions and unless there are no other alternatives, it should not be used in older persons.

T&F logoTaylor & Francis Group logo
  • Policies
    • Privacy Policy
    • Terms & Conditions
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
    • Cookie Policy
  • Journals
    • Taylor & Francis Online
    • CogentOA
    • Taylor & Francis Online
    • CogentOA
  • Corporate
    • Taylor & Francis Group
    • Taylor & Francis Group
    • Taylor & Francis Group
    • Taylor & Francis Group
  • Help & Contact
    • Students/Researchers
    • Librarians/Institutions
    • Students/Researchers
    • Librarians/Institutions
  • Connect with us

Connect with us

Registered in England & Wales No. 3099067
5 Howick Place | London | SW1P 1WG © 2021 Informa UK Limited